Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
about
Medical versus surgical treatment for refractory or recurrent peptic ulcerNon-invasive diagnostic tests for Helicobacter pylori infectionMedical versus surgical treatment for refractory or recurrent peptic ulcerH. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerA turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityTime dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachCurrent concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportPathogenesis of Helicobacter pylori infectionThe stomach in health and diseaseGastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatmentRole of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug usersPractical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDsBalancing the gastrointestinal benefits and risks of nonselective NSAIDs.Peptic ulcer disease todayPrimary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national surveyPeptic ulcer disease in a general adult population: the Kalixanda study: a random population-based studyReview article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppressionThe prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) studyAdverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tractPrevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategiesPrimer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risksCurrent approaches to prevent NSAID-induced gastropathy--COX selectivity and beyondShould we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsUp-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysisInteraction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseasesMolecular mechanisms in therapy of acid-related diseasesExternal validation of a measurement tool to assess systematic reviews (AMSTAR).Helicobacter pylori infection: approach of primary care physicians in a developing country.Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.Celecoxib inhibits Helicobacter pylori colonization-related factors.Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysisA review of the gastrointestinal safety data--a gastroenterologist's perspective.Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.A practical approach to the treatment of low-risk childhood fever.Risk factors and therapeutic response in Chinese patients with peptic ulcer disease.One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable.Approach to Helicobacter pylori infection in geriatric population.Virulence genes of Helicobacter pylori in the Dominican Republic.
P2860
Q24186004-698C5680-7AC8-4E49-A990-6CC8064E80B8Q24186187-EE54ACB7-7A99-4AB8-82F7-E46C6F50D8B2Q24186307-FFE25331-F362-452A-B6D9-251E4F237F8DQ24248627-1AEB7A32-69D0-4869-8D40-58CC9D88B613Q24615651-938DC472-9794-47AE-8A7A-8283715B66BBQ24673561-A6905BB8-C283-4DBA-89FD-E7392292DE92Q24674636-ABF62091-A621-4EFF-8847-293645ADA4A1Q24679810-21576B2E-D2F9-41AE-89DC-13D0A2B6E360Q26784036-AC852EB9-8092-4599-9747-0FB9AADA9956Q27027977-C009A41E-FAAA-430C-9714-7888A8B27AA7Q28182449-CE645EAA-E54B-42EC-9C14-E9741B37D3FBQ28191928-CB94211A-43DB-4E2A-A9F9-ECB53D87B4F0Q28191932-1828C2E4-E349-4B84-8493-E0AA3286E580Q28194844-44692BD6-8D70-4A5E-8FD5-647026AB0484Q28195079-139DBAA8-D12C-4C69-9BAE-B6AB0395CBA3Q28195892-89C951CB-36E3-4990-A3BA-6F0097ED9500Q28195953-3A080BDE-56FD-48F7-8C64-60748E13D763Q28196518-92977ACA-D7E7-4481-8D59-FBD9DC0AA43BQ28199102-81E07BDC-02B2-442F-A201-09F1209B35D4Q28200569-EB8A8D14-2838-4E0B-84C7-C40742679910Q28200571-4AC9C5D7-6504-4E8B-A034-771E307E4186Q28210656-E7228DA2-D72B-4BFC-987F-E962C22E8C45Q28211894-07213C07-4B1B-4324-B125-E1CAC7C69D5BQ28213638-6C23EC9A-8570-4E57-A329-59BC68E6A0B6Q28217824-248C77DF-B6A7-4DC0-B3E7-8D9312D076EDQ28218938-F946C142-7FF1-411D-BB34-F1C33E207428Q28219634-368658E9-8D33-42CA-81AE-01BF7E946704Q28252872-E6DE89B1-A941-432C-933A-CAAE6E2F7970Q33312366-19240A25-5401-4F81-88BA-CA79D9E74DC7Q33428773-31EE92ED-3A91-4511-B54E-5DBAB0480967Q33432343-CE540E5E-2F29-46C5-B132-735469043D2BQ33530350-E3B82C07-5048-4816-8A5C-2ABCB1AA2F99Q33530352-B10B170F-5472-4FA8-9226-17EFFF1C205EQ33560647-7DFC8888-BF31-4B5E-BEF1-CFCFC85A2A72Q33698340-A0519D1A-8B94-4708-8577-478D4F4E0107Q33804779-8AFE2E77-B28C-49FB-9C3F-300A4EEDAF58Q33812202-BE58EF59-006B-470E-B330-7EA7074C3D92Q34036732-BC73F8CE-FF80-4C12-8A12-B4CA4D33C0CDQ34047658-4039757A-481E-4110-BE59-9F259B8CF4BCQ34073186-BBBFA2A3-0763-4BF6-8416-F575C7A5ED4C
P2860
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@ast
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@en
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@nl
type
label
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@ast
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@en
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@nl
prefLabel
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@ast
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@en
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@nl
P2093
P1433
P1476
Role of Helicobacter pylori in ...... lcer disease: a meta-analysis.
@en
P2093
Jia Qing Huang
Richard H Hunt
Subbaramiah Sridhar
P356
10.1016/S0140-6736(02)07273-2
P407
P577
2002-01-01T00:00:00Z